StoxBiopol Chemicals Limited
NSE: BIOPOL · Unclassified
Ask the data
Instant answers about Biopol Chemicals Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY26 | |
|---|---|
| Revenue | 81.1 |
| EBITDA | 13.4 |
| Operating margin | 16.6% |
| Interest | 1.5 |
| Depreciation | 0.1 |
| Profit before tax | 12.1 |
| Tax | 3.1 |
| Net profit | 9.0 |
| EPS ₹ | 10.83 |
| Operating cash flow | -12.8 |
| Capex | 14.1 |
| Dividend paid | 0.0 |
| Total assets | 69.8 |
| Equity | 49.9 |
Half-yearly performance
last 3 half years · ₹ crore| H1 FY26* | H2 FY26 | H1 FY27 | |
|---|---|---|---|
| Revenue | 31.6 | 49.5 | 45.1 |
| Operating profit | 4.4 | 9.0 | 8.1 |
| Operating margin | 14.0% | 18.2% | 17.9% |
| Other income | 0.1 | 0.1 | 0.2 |
| Interest | 0.5 | 1.0 | 0.8 |
| Depreciation | 0.0 | 0.1 | 0.2 |
| Profit before tax | 4.0 | 8.1 | 7.3 |
| Tax | 1.0 | 2.1 | 2.0 |
| Net profit | 2.9 | 6.0 | 5.3 |
| EPS ₹ | 4.65 | 6.18 | 4.91 |
| Revenue YoY | — | — | 42.5% |
| Profit YoY | — | — | 81.2% |
Returns & margins
trailing-twelve-month, per half year| H2 FY26 | H1 FY27 | |
|---|---|---|
| ROE | 18.0% | 20.6% |
| ROCE | 23.3% | 23.4% |
| Net margin | 11.1% | 12.0% |
| EBITDA margin | 16.6% | 18.1% |
| Debt / equity | 0.17 | 0.33 |
| Interest coverage | 8.93 | 9.74 |
| Asset turnover | 1.16 | 1.14 |
Balance sheet
equity vs borrowings over time · ₹ crore| MAR '26 | SEP '26 | |
|---|---|---|
| Share capital | 10.8 | 10.8 |
| Other equity / reserves | 39.1 | 44.4 |
| Total equity | 49.9 | 55.2 |
| Borrowings | 8.5 | 18.0 |
| Current liabilities | 14.7 | 23.1 |
| Non-current liabilities | 5.1 | 4.8 |
| Total assets | 69.8 | 83.1 |
| Property, plant & equipment | 14.2 | 14.3 |
| Investments | 0.0 | 0.0 |
| Inventories | 19.6 | 25.4 |
| Receivables | 27.8 | 25.9 |
| Cash & equivalents | 0.5 | 0.1 |
Cash flow
annual · ₹ crore · line = free cash flow| FY26 | |
|---|---|
| Cash from operations | -12.8 |
| Cash from investing | -14.5 |
| Cash from financing | 26.7 |
| Capex | 14.1 |
| Free cash flow | -26.9 |
| Dividends paid | 0.0 |
Where the assets sit
Sep '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Biopol Chemicals Limited | 51 | 47.00 | 4.5 | 0.92 | 20.6% |
StoxGud checklist: Neutral setup · 6/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Biopol Chemicals Limited?
Biopol Chemicals Limited (BIOPOL) closed at ₹47.00 on NSE on 06 Nov 2026.
What is the market cap of Biopol Chemicals Limited?
₹51 crore at the latest close.
What is the P/E ratio of Biopol Chemicals Limited?
4.5, on trailing-twelve-month earnings from its filings.
How fast is Biopol Chemicals Limited growing?
Biopol Chemicals Limited: Latest-half-year revenue is up 42.5% year on year, profit up 81.2%.
How profitable is Biopol Chemicals Limited?
On a trailing-twelve-month basis return on equity is 20.6%, return on capital employed 23.4%, operating margin 18.1%, net margin 12.0%.
How much debt does Biopol Chemicals Limited have?
Biopol Chemicals Limited is lightly geared: debt to equity is 0.33 with borrowings of ₹18 cr against cash of ₹0 cr (balance sheet of 2026-09-30). Operating profit covers interest 9.7 times.
Financials parsed from Biopol Chemicals Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Half-yearly from H1 FY26, annual from FY26, balance sheet from Mar '26. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.